dnc_email_00151.txt
…GPhA's Christine Simmon: "We have serious concerns that the demonstration, as proposed, risks limiting the savings created through open market competition, particularly in the nascent biosimilars market. We strongly encourage the agency to carefully consider thoughtful changes to both…
Comments